All In Biotech

Free tool

FAERS Monitor: Cefazolin and Dextrose

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050779 or its brand name (Cefazolin and Dextrose, Cefazolin Sodium). Reports on generic versions are filed under their own applications.

Reports

3,023

Serious

2,872

95% of reports

Hospitalization

1,452

Death reported

362

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • anaphylactic shock270
  • anaphylactic reaction164
  • hypotension154
  • pyrexia137
  • rash131
  • anaemia92
  • erythema92
  • nausea88
  • off label use84
  • pneumonia84
  • urticaria84
  • tachycardia83
  • diarrhoea74
  • pruritus74
  • hepatic function abnormal72

Reports by year received

View as table
YearReports
200429
200555
200644
200743
200853
200927
201050
2011106
2012192
201345
201456
201574
2016117
201783
2018121
2019148
2020148
2021139
2022296
2023318
2024357
2025319
2026203

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,136 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
anaphylactic shockSignal27073.665.719,097
anaphylactic reactionSignal16420.717.83,055
hepatic function abnormalSignal7213.410.7817
tachycardiaSignal836.55.3382
hypotensionSignal1545.34.6544
urticariaSignal843.52.8148
anaemiaSignal923.42.7151
erythemaSignal923.12.5131
pyrexiaSignal1372.82.3154
rashSignal1312.11.875
pneumonia841.81.530
pruritus741.31.16
diarrhoea740.80.64
nausea880.80.66
off label use840.70.514

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.